Chargement en cours...
Augmentation of the therapeutic efficacy of WEE1 kinase inhibitor AZD1775 by inhibiting the YAP–E2F1–DNA damage response pathway axis
The main reasons for failure of cancer chemotherapy are intrinsic and acquired drug resistance. The Hippo pathway effector Yes‐associated protein (YAP) is associated with resistance to both cytotoxic and molecular targeted drugs. Several lines of evidence indicate that YAP activates transcriptional...
Enregistré dans:
| Publié dans: | FEBS Open Bio |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5986022/ https://ncbi.nlm.nih.gov/pubmed/29928579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/2211-5463.12440 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|